In patients with T1DM, when would you consider the use of amylin analogues for control of post prandial hyperglycemia?
Community PollStarted
When would you consider the use of amylin analogues for control of post prandial hyperglycemia in patients with Type 1 diabetes?
19 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Endocrinology · MedStar Health
Answered on
Pramlintide was FDA-approved in 2005 after demonstrating modest A1C reduction, improvement in post-prandial hyperglycemia, no increase in hypoglycemia, and some weight loss. I prescribed it to several of my patients with type 1 diabetes. Unfortunately, many of them had challenges such as GI side eff...
Join for free or sign in to see the full answer